is losing billions of dollars to break into Japan’s wireless market, said he’s devoting a fifth of his time to a US-based biotech startup for cancer treatments, describing it as “a social project” where profitability isn’t a top priority.
“I don’t think there’s a problem with the use of my time,” Mikitani said in an interview in Yokohama, Japan, where he spoke at conference held by the
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: